Serum Markers in Lung Cancer Patients
Author Information
Author(s): Schneider J, Presek P, Braun A, Bauer P, Konietzko N, Wiesner B, Woitowitz H-J
Primary Institution: Justus-Liebig Universität Giessen
Hypothesis
Can serum levels of EGF-R, p53 protein, and anti-p53 antibodies serve as diagnostic biomarkers for lung cancer in patients with occupational exposure?
Conclusion
The study found that serum levels of p53 protein, EGF-R, and anti-p53 antibodies are not useful as routine biomarkers for screening occupationally derived lung cancers.
Supporting Evidence
- Increased levels of EGF-R, p53 protein, and anti-p53 antibodies were reported in lung cancer patients after occupational asbestos exposure.
- The study included 116 male patients with various types of lung tumors.
- No significant serum value differences were found based on tumor type or exposure.
Takeaway
Doctors looked at certain proteins in the blood of lung cancer patients to see if they could help find cancer earlier, but they didn't work well.
Methodology
The study measured serum levels of EGF-R, p53 protein, and anti-p53 antibodies using an enzyme-linked immunosorbent assay.
Limitations
No significant differences in serum values were found based on tumor type, age, or exposure type.
Participant Demographics
116 male patients with lung or pleural tumors and 50 male patients with non-malignant lung diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website